Randomized trial of activated vitamin D for acute kidney injury prevention in critically ill patients.

Despite promising laboratory data, giving critically ill patients at high risk of kidney injury active vitamin D (calcifediol or calcitriol) did not prevent acute kidney injury compared with placebo, though it did shift immune-related gene activity.